Top Factor Driving Infusion Therapy Devices Market Growth in 2025: Increasing Prevalence Of Chronic Diseases Is Driving The Growth Of The Market

What industry-specific factors are fueling the growth of the infusion therapy devices market?
The surge in chronic diseases is predicted to fuel infusion therapy devices market expansion in the future. Chronic illnesses are those health issues that persist for over a year, necessitate constant medical care, and hamper daily life activities. Factors like unhealthy lifestyles, sedentary behavior, poor nutrition, environmental impacts, and an increase in risk elements like obesity, smoking, and stress can contribute to the rise in chronic illnesses. Infusion therapy devices significantly aid in managing chronic illnesses by delivering precise and controlled medication and fluid directly into the bloodstream. This ensures consistent and efficient treatment for ailments such as diabetes, autoimmune diseases, and cancer, thereby elevating patient outcomes, boosting convenience, and reducing frequent hospital visits. For instance, according to a projection by the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, in January 2023, it is expected that by 2050, there will be a 99.5% increase in individuals aged 50 years and above suffering from at least one chronic disease, rising from 71.522 million in 2020 to 142.66 million. Therefore, the escalating prevalence of chronic diseases is steering the growth of the infusion therapy devices market.

Get Your Infusion Therapy Devices Market Report Here:
https://www.thebusinessresearchcompany.com/report/infusion-therapy-devices-global-market-report

What Is the projected market size and growth rate for the infusion therapy devices market?
The market for infusion therapy devices has been experiencing swift growth in the past few years. Its value, expected to be at $12.10 billion in 2024, is projected to increase to $13.43 billion in 2025, indicating a compound annual growth rate (CAGR) of 11.0%. This significant expansion during the historical period can be attributed to factors such as a rise in hospital admissions, enhancements in healthcare infrastructure, policies initiated by the government, an increase in medical tourism, and improved reimbursement policies.

The market size of infusion therapy devices is projected to achieve swift expansion in the upcoming years, with predictions of reaching $20.11 billion in 2029 courtesy of a compound annual growth rate (CAGR) of 10.6%. Factors such as the influence of personalized medicine, the preparedness and response to pandemics, the advent of wearable infusion devices, the shift towards infusion therapy, and the digitalization of healthcare are anticipated to drive the growth during the forecast period. Emerging trends that are expected to shape the market in the forecast period consist of 5G connectivity, quantum computing, integration of the internet of things (IoT), wearable health technology, and the use of voice assistants and natural language processing.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20849&type=smp

What new trends are reshaping the infusion therapy devices market and its opportunities?
Leading companies in the infusion therapy devices sector are concentrating on the creation of innovative solutions such as Pressure-Enabled Drug Delivery (PEDD) technology to improve liver and pancreatic tumor treatments. PEDD is a method of drug administration that uses pressure to enhance the infusion of therapeutic substances into tissues or organs, especially where traditional techniques may encounter difficulties. For example, TriSalus Life Sciences, a medical technology firm based in the United States, debuted the TriNav LV Infusion System and TriGuide Guiding Catheters in November 2024. This expanded their PEDD product range, optimizing therapeutic application, increasing treatment possibilities, and potentially boosting patient outcomes. The TriNav LV Infusion System, notably, offers distinctive features including larger blood vessels (3.5 to 5.0 mm), broadening the applicability of TriSalus' PEDD technology to a wider demographic of patients. This product release broadens PEDD device compatibility from vessels of 1.5 mm to 5.0 mm, presenting more treatment choices for interventional radiologists. With an increased inner diameter, a slippery lining, and a reverse curve design for simpler femoral access and better procedural efficiency, the TriGuide Guiding Catheters have been very well received. Preliminary users have reported a 97% satisfaction rate, underscoring the system's efficiency and user-friendliness in oncology treatments.

What major market segments define the scope and growth of the infusion therapy devices market?
The infusion therapy devices market covered in this report is segmented -

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors
2) By Mobility: Portable Infusion Pumps, Stationary Pumps
3) By Application: Oncology, Diabetes, Pain Management, Other Applications
4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users

Subsegments:
1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps
2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters
3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas
4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20849

Which region dominates the infusion therapy devices market?
North America was the largest region in the infusion therapy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infusion therapy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the infusion therapy devices industry growth?
Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, Acelity L.P Inc., LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., AccuVein Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20849&type=smp

What Is Covered In The Infusion Therapy Devices Global Market Report?

•Market Size Forecast: Examine the infusion therapy devices market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the infusion therapy devices market for a structured understanding.
•Key Players Overview: Analyze major players in the infusion therapy devices market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the infusion therapy devices market.
•Segment Contributions: Evaluate how different segments drive overall growth in the infusion therapy devices market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the infusion therapy devices market.
•Industry Challenges: Identify potential risks and obstacles affecting the infusion therapy devices market.
•Competitive Landscape: Review strategic developments in the infusion therapy devices market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.